To the extent possible under law, the person who associated CC0 with this work has waived all copyright and related or neighboring rights to this work.
DRAVP ID DRAVPa1846
Peptide Name Sequence 8 from Patent US20170058000 B2
Sequence HGNHGVLA
Sequence Length 7
Source Synthetic construct
Target Organism H3N2
Patent Type Granted Patent
Publication Date 2018-11-13
Patent No US20170058000 B2
Patent Title Bioactive peptide complexes
Comment
Abstract The proposed invention relates to proteins and biologically active peptides with immuno-modulating and antiviral activity. The proposed peptide complexes have a three-dimensional structure and are described by the following structural formula: wherein X1 is either not present or contains no less than 1 amino acid and R1 and R2 are peptide chains containing the amino acid residues His or Cys capable of interacting with ions of transition metals, wherein R1 contains up to 5 amino acid residues or is not present and R2 contains up to 18 amino acid residues or is not present. Complexes of peptides enriched with histidine, especially peptides of the alloferon family with Zn ions, will enable the creation of preparations with targeted mechanisms of action and will make it possible to design such preparations according to an understanding of the structure of the medicinal target.
To the extent possible under law, the person who associated CC0 with this work has waived all copyright and related or neighboring rights to this work.